617.50
-9.25
(-1.48%)
As of 2:42:38 PM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
36,895,581
35,302,681
33,620,094
31,527,196
28,542,519
Cost of Revenue
11,923,467
11,821,367
12,237,710
10,730,664
9,460,987
Gross Profit
24,972,114
23,481,314
21,382,384
20,796,532
19,081,532
Operating Expense
16,614,298
15,826,898
15,227,322
14,620,562
13,845,927
Operating Income
8,357,816
7,654,416
6,155,062
6,175,970
5,235,605
Net Non Operating Interest Income Expense
30,950
25,550
27,310
227,070
38,096
Pretax Income
8,693,928
7,908,328
6,695,494
6,880,050
5,689,214
Tax Provision
820,768
666,968
421,379
-1,486,600
1,142,126
Net Income Common Stockholders
7,931,897
7,235,297
6,395,720
8,389,850
4,546,991
Diluted NI Available to Com Stockholders
7,931,897
7,235,297
6,395,720
8,389,850
4,546,991
Basic EPS
18.17
16.55
14.50
18.88
10.23
Diluted EPS
18.17
16.55
14.50
18.88
10.23
Basic Average Shares
436,662.97
437,265
441,150
444,377.65
444,476.15
Diluted Average Shares
436,662.97
437,265
441,150
444,377.65
444,476.15
Rent Expense Supplemental
--
112,440
114,020
68,521
46,733
Total Expenses
28,537,765
27,648,265
27,465,032
25,351,226
23,306,914
Net Income from Continuing & Discontinued Operation
7,931,897
7,235,297
6,395,720
8,389,850
4,546,991
Normalized Income
7,738,975.81
7,094,254.75
5,951,627.89
8,011,934
4,243,189.17
Interest Income
--
125,322
101,224
277,799
170,809
Interest Expense
94,372
99,772
73,914
50,729
132,713
Net Interest Income
30,950
25,550
27,310
227,070
38,096
EBIT
8,788,300
8,008,100
6,769,408
6,930,779
5,821,927
EBITDA
10,615,159
9,867,159
9,241,898
10,278,558
9,491,475
Reconciled Cost of Revenue
11,923,467
11,821,367
12,237,710
10,730,664
9,460,987
Reconciled Depreciation
1,826,859
1,859,059
2,472,490
3,347,779
3,669,548
Net Income from Continuing Operation Net Minority Interest
7,931,897
7,235,297
6,395,720
8,389,850
4,546,991
Total Unusual Items Excluding Goodwill
213,033
154,033
473,918
539,880
380,110
Total Unusual Items
213,033
154,033
473,918
539,880
380,110
Normalized EBITDA
10,402,126
9,713,126
8,767,980
9,738,678
9,111,365
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
20,111.81
12,990.75
29,825.89
161,964
76,308.17
3/31/2021 - 8/3/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COLPAL.NS Colgate-Palmolive (India) Limited
2,580.00
+1.11%
JYOTHYLAB.BO Jyothy Labs Limited
375.65
-0.29%
GILLETTE.NS Gillette India Limited
7,825.00
+0.25%
CL.BA Colgate-Palmolive Company
36,625.00
-6.11%
GODREJCP.NS Godrej Consumer Products Limited
1,237.80
-0.55%
PGHH.NS Procter & Gamble Hygiene and Health Care Limited
14,143.00
+0.81%
MARICO.NS Marico Limited
714.75
-0.79%
JYOTHYLAB.NS Jyothy Labs Limited
375.55
-0.36%
BAJAJCON.NS Bajaj Consumer Care Limited
174.60
+1.71%
DABUR.BO Dabur India Limited
479.20
-0.44%